“RSVVW 2019” A Global Conference on Novel RSV Preventive and Therapeutic Interventions, was held on November 12th-14th, 2019 in Accra, Ghana.  We look back on a successful, exciting and inspiring meeting. 
Almost 300 attendees from 43 countries from 5 continents attended the conference. There were 58 travel grants: 34 LMIC participants and 24 Young Researchers, 100 posters and over 45 Key note speakers.
We are more than thankful that you attended our conference and hope you enjoyed the experience.

Watch back PosterSessions

Watch back the RSVVW2019

Presentation slides

Scientific Program

The program consists of the following session topics:

• Session I: Burden of RSV Disease and Mortality
• Session II: Latest Developments in RSV Molecular Virology
• Session III: RSV Immunology: Identification of Novel Therapeutic Targets
• Session IV: Clinical Advancements of RSV Prevention
• Session V: Clinical Advancements of RSV Treatment
• Session VI: Status of RSV Interventions – By Companies
• Session VII: RSV-Related Recurrent Wheeze and Asthma
• Session VIII: RSV Infection - A Global Health Perspective

Scientific Program

See All Photo's

The conference is held bi-annually and alternates with the ISIRV RSV Symposium. The main goal of this conference is to offer a platform for updates relevant to the RSV community, with a focus around interventions for RSV prevention and treatment. We aim to bring together stakeholders involved in RSV research such as scientists, physicians, pharmaceutical companies, and representatives from FDA, PATH, WHO, EMA, NIH, and BMGF to discuss updates and next steps to advance interventions against RSV disease.
​Researchers, physicians, and companies from around the world are invited to join the discussion and share their knowledge. Specifically, scientists and physicians from low- and middle-income countries and young researchers are encouraged to attend and may apply to receive support. This meeting is a great forum to discuss opportunities for future international collaboration and achievements in the RSV field. 

contact

Please contact us if you have any questions regarding our upcoming conference:

LEYLA KRAGTEN-TABATABAIE
+31 (0)6 113 313 91

email Leyla

ORGANIZING COMMITTEE

Tracy Ruckwardt
Viral Pathogenesis Laboratory and Translational Science Core & National Institute of Allergy and Infectious Diseases, Bethesda, United States
Marta Nunes
University of Witwatersrand, Johannesburg, South Africa & Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa
Natalie Mazur 
Wilhelmina Children’s Hospital University Medical Center Utrecht, Utrecht, The Netherlands
Louis Bont
Board ReSViNET, Wilhelmina Children’s Hospital University Medical Center Utrecht, Utrecht, The Netherlands
Leyla Kragten-Tabatabaie
Board of Directors ReSViNET Foundation, Julius Clinical, Zeist

SCIENTIFIC ADVISORY COMMITTEE

Barney Graham
Viral Pathogenesis Laboratory and Translational Science Core & National Institute of Allergy and Infectious Diseases, Bethesda, United States
Deborah Higgins
RSV Vaccine Project at PATH, Seattle, Washington, United States
Beate Kampmann
Professor of Paediatric Infection & Immunity, Director of The Vaccine Centre (LSHTM) - London, United Kingdom
Heather Zar
Department of Pediatrics & Child Health at Red Cross Children’s Hospital (University of Cape Town) - Cape Town, South Africa
Octavio Ramilo
The Research Institute at Nationwide Children's Hospital, Columbus, United States
James Nokes
Professor of Infectious Disease Epidemiology, University of Warwick, UK
Wellcome Trust Senior Investigator, KEMRI-Wellcome Trust, Kenya

RSVVW'19 Sponsors